Indapamid Rivopharm (Indapamide)

Indapamide blocks the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urine output, decreased plasma volume, and lowered peripheral vascular resistance, which together lower blood pressure and relieve edema.

The appropriate dose of Indapamid Rivopharm is determined by the prescribing physician based on the patient’s clinical condition, response to therapy, and renal function. Dosage adjustments are individualized, and patients should follow the exact regimen provided by their healthcare professional.

The safety of indapamide in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Indapamide is a thiazide‑like diuretic that offers a longer duration of action and a lower incidence of metabolic side effects compared with some classic thiazides. It is often preferred when a sustained blood‑pressure‑lowering effect is needed, but the choice depends on individual patient factors and physician judgment.

Indapamid Rivopharm should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Indapamid Rivopharm is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the specific instructions given by their prescriber to maintain consistent absorption and effect.

Serious risks include severe electrolyte disturbances (especially low potassium), acute kidney injury, marked hypotension, and rare allergic reactions such as rash or swelling. Patients should be monitored regularly for these complications, particularly during the initial phase of therapy.

Indapamid Rivopharm is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide diuretics, severe renal impairment, and in those with anuria. Caution is also advised for individuals with uncontrolled diabetes, gout, or electrolyte imbalances.